Miguel D'haeseleer

Summary

Affiliation: Universitair Ziekenhuis Brussel
Country: Belgium

Publications

  1. doi request reprint Vascular aspects of multiple sclerosis
    Miguel D'haeseleer
    Department of Neurology, Universitair Ziekenhuis Brussel, Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium
    Lancet Neurol 10:657-66. 2011
  2. pmc Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1
    Miguel D'haeseleer
    Department of Neurology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium
    Proc Natl Acad Sci U S A 110:5654-8. 2013
  3. ncbi request reprint The role of cytotoxic drugs in the treatment of central nervous system gliomas
    Bart Neyns
    Medical Oncology, UZ Brussel, Brussels, Belgium
    Acta Neurol Belg 110:1-14. 2010
  4. doi request reprint Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome
    Kris Poppe
    Department of Endocrinology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
    Fertil Steril 96:241-5. 2011
  5. ncbi request reprint Astrocyte loss and astrogliosis in neuroinflammatory disorders
    Stephanie Hostenbach
    Department of Neurology, Center for Neurosciences, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel VUB, Brussel, Belgium
    Neurosci Lett 565:39-41. 2014
  6. pmc White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis
    Melissa Cambron
    Department of Neurology, Center for Neurosciences, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussel, Belgium
    J Cereb Blood Flow Metab 32:413-24. 2012

Collaborators

Detail Information

Publications6

  1. doi request reprint Vascular aspects of multiple sclerosis
    Miguel D'haeseleer
    Department of Neurology, Universitair Ziekenhuis Brussel, Center for Neurosciences, Vrije Universiteit Brussel, Brussels, Belgium
    Lancet Neurol 10:657-66. 2011
    ....
  2. pmc Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1
    Miguel D'haeseleer
    Department of Neurology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium
    Proc Natl Acad Sci U S A 110:5654-8. 2013
    ..Restoring CBF by interfering with the ET-1 system warrants further investigation as a potential new therapeutic target for MS...
  3. ncbi request reprint The role of cytotoxic drugs in the treatment of central nervous system gliomas
    Bart Neyns
    Medical Oncology, UZ Brussel, Brussels, Belgium
    Acta Neurol Belg 110:1-14. 2010
    ..Phase III clinical studies evaluating combinations of these new agents with classical cytotoxic agents in first and in second line have recently been initiated...
  4. doi request reprint Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome
    Kris Poppe
    Department of Endocrinology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
    Fertil Steril 96:241-5. 2011
    ..To investigate the impact of ovarian hyperstimulation syndrome (OHSS) on thyroid function in women without thyroid disorders and to compare it with that in women with uncomplicated controlled ovarian hyperstimulation (COH)...
  5. ncbi request reprint Astrocyte loss and astrogliosis in neuroinflammatory disorders
    Stephanie Hostenbach
    Department of Neurology, Center for Neurosciences, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel VUB, Brussel, Belgium
    Neurosci Lett 565:39-41. 2014
    ..Other mechanisms, such as astrocytic β2 adrenergic receptor deficiency, upregulation of endothelin-1 and tissue transglutaminase, may contribute to astroglial scarring in multiple sclerosis. ..
  6. pmc White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis
    Melissa Cambron
    Department of Neurology, Center for Neurosciences, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussel, Belgium
    J Cereb Blood Flow Metab 32:413-24. 2012
    ..White-matter astrocytes may be considered as a potential target for neuroprotective MS therapies...